Brief: Inhalerx Seeks Trading Halt
15/09/2022 24:22
Sept 15 (Reuters) - Inhalerx Ltd IRX.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CAPITAL RAISING
Source text for Eikon: ID:nASX7kb3G7
Further company coverage: IRX.AX
Recent news on Nexalis Therapeutics
See all newsBrief: Nexalis Therapeutics Says Sean Williams Has Resigned As Non-Executive Chairman
Brief: Nexalis Therapeutics Signs Funding Partnership With Point8 Capital To Replace Existing Facility
Brief: Nexalis Therapeutics Seeks Trading Halt
Brief: Nexalis Therapeutics Says US Policy Market Advancement Supports SRX-25 TRD Treatment
Australia's Nexalis Therapeutics gains most in over 6 months on trial approval